Literature DB >> 7237411

Malignant epithelial tumors of the anal canal.

R Singh, F Nime, A Mittelman.   

Abstract

A simplified staging for malignant epithelial tumors of the anal canal is presented. The pattern of recurrence in males is pelvic and perineum, in females pelvis and posterior vaginal wall. Concomitant posterior vaginectomy is advocated. The disease is more common in females than males (4:1). There is little difference between histologic types, i.e. cloacagenic or squamous cell type. Recurrence and survival depend upon depth of invasion and extent of spread rather than histologic cell type. The tumors respond to well-designed surgery, radiotherapy and probably chemotherapy.

Entities:  

Mesh:

Year:  1981        PMID: 7237411     DOI: 10.1002/1097-0142(19810715)48:2<411::aid-cncr2820480232>3.0.co;2-z

Source DB:  PubMed          Journal:  Cancer        ISSN: 0008-543X            Impact factor:   6.860


  11 in total

1.  Identification of epithelial label-retaining cells at the transition between the anal canal and the rectum in mice.

Authors:  Laura A Runck; Megan Kramer; Georgianne Ciraolo; Alfor G Lewis; Géraldine Guasch
Journal:  Cell Cycle       Date:  2010-08-20       Impact factor: 4.534

2.  Multimodal therapy of anal cancer added by new endosonographic-guided brachytherapy.

Authors:  J M Doniec; B Schniewind; G Kovács; V Kahlke; M Loehnert; B Kremer
Journal:  Surg Endosc       Date:  2006-01-21       Impact factor: 4.584

3.  Phase II study of combination bleomycin, vincristine and high-dose methotrexate (BOM) with leucovorin rescue in advanced squamous cell carcinoma of the anal canal.

Authors:  N Wilking; N Petrelli; L Herrera; A Mittelman
Journal:  Cancer Chemother Pharmacol       Date:  1985       Impact factor: 3.333

Review 4.  Anal cancer treatment: current status and future perspectives.

Authors:  Marwan Ghosn; Hampig Raphael Kourie; Pamela Abdayem; Joelle Antoun; Dolly Nasr
Journal:  World J Gastroenterol       Date:  2015-02-28       Impact factor: 5.742

5.  A comparison between 5-fluorouracil/mitomycin and capecitabine/mitomycin in combination with radiation for anal cancer.

Authors:  Renata D'Alpino Peixoto; Dante D Wan; Devin Schellenberg; Howard J Lim
Journal:  J Gastrointest Oncol       Date:  2016-08

6.  Anal epidermoid carcinoma: a population-based clinico-pathological study of 164 patients.

Authors:  S Goldman; B Glimelius; L Påhlman; E Ståhle; E Wilander
Journal:  Int J Colorectal Dis       Date:  1988-06       Impact factor: 2.571

7.  Prognostic factors for squamous cell cancer of the anal canal.

Authors:  Prajnan Das; Christopher H Crane; Cathy Eng; Jaffer A Ajani
Journal:  Gastrointest Cancer Res       Date:  2008-01

8.  Overview of Recent Trends in the Management of Metastatic Anal Cancer.

Authors:  Mahender Yellu; Ayham Deeb; Olugbenga Olowokure
Journal:  World J Oncol       Date:  2015-02-14

9.  Patterns of anal carcinoma by gender and marital status in Los Angeles County.

Authors:  R K Peters; T M Mack
Journal:  Br J Cancer       Date:  1983-11       Impact factor: 7.640

10.  Presenting symptoms predict local staging of anal cancer: a retrospective analysis of 86 patients.

Authors:  Matthias Sauter; Georg Keilholz; Helmut Kranzbühler; Norbert Lombriser; Meher Prakash; Stephan R Vavricka; Benjamin Misselwitz
Journal:  BMC Gastroenterol       Date:  2016-04-06       Impact factor: 3.067

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.